StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie wholesaler Chargebacks — Provisions ($M) ($M)

Form 10-K Item 7 MD&A Rebates & Chargebacks Rollforward

Latest, FY2025
17,710
Period ended Dec 31, 2025
Change on a year earlier
+19.8%
14,782 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). AbbVie Wholesaler Chargebacks — Provisions ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn_chargebacks_prov

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.